NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits. It also offers equipment and technologies for hydraulic fracture stimulation, including downhole multistage fracturing tools, pressure pumping trucks, blenders, sanders, hydration and injection units, flowline, and manifolds; coiled tubing units, and wireline units and tools; connections and liner hangers; onshore production consists of composite pipe, surface transfer and progressive cavity pumps, and artificial lift systems; and offshore production, such as floating production systems and subsea production technologies, as well as manufactures industrial pumps and mixers. In addition, the company provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; pressure control equipment; drives and generators; rig instrumentation and control systems; mooring, anchor, and deck handling machinery; equipment components for offshore wind construction vessels; and pipelay and construction systems. Further, the company offers spare parts, repair, and rentals as well as comprehensive remote equipment monitoring, technical support, field service, and customer training. The company was formerly known as National Oilwell Varco, Inc. and changed its name to NOV Inc. in January 2021. NOV Inc. was founded in 1862 and is based in Houston, Texas.

NOV Inc.

Morgan Stanley analyst Thibault Boutherin maintained a Buy rating on Novartis AG yesterday. The company’s shares closed today at CHF100.42. Bouther...

Morgan Stanley Reaffirms Their Buy Rating on Novartis AG (NOVN)

Bernstein analyst Florent Cespedes maintained a Buy rating on Novartis AG yesterday and set a price target of CHF108.00. Cespedes covers the Health...

Bernstein Keeps Their Buy Rating on Novartis AG (NOVN)

Saudi Arabian Oil, also known as Aramco, signed new deals with a wide set of U.S. firms. The plan took shape at the U.S.-Saudi Investment Forum in ...

Aramco Strikes Up to $30 billion in U.S. Energy and LNG Deals at Washington Forum

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novo Nordisk, with a price target of DKK315.00. According to TipRan...

UBS Remains a Hold on Novo Nordisk (0QIU)

Berenberg Bank analyst Luisa Hector maintained a Hold rating on Novartis AG today and set a price target of CHF92.00. According to TipRanks, Hector...

Berenberg Bank Sticks to Its Hold Rating for Novartis AG (NOVN)

Novatti Group ( ($AU:NOV) ) has issued an announcement. Novatti Group Limited announced that its AUDD stablecoin has surpassed $1 billion in transa...

Novatti’s AUDD Stablecoin Surpasses $1 Billion in Stellar Blockchain Transactions

The latest announcement is out from Novo Nordisk ( ($NVO) ). On November 17, 2025, Novo Nordisk announced transactions involving its shares by boar...

Novo Nordisk Announces Insider Share Transactions

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Novanta (NOVT – Research Report) and Applied Digital...

Analysts Offer Insights on Technology Companies: Novanta (NOVT) and Applied Digital Corporation (APLD)

An update from Novamarine S.P.A. ( ($IT:NOVA) ) is now available. Novamarine S.p.A. has approved a capital increase and a shareholder loan for its ...

Novamarine Boosts Tornado Boat Production with Capital Increase and Loan

In a report released on November 14, David Evans from Kepler Capital maintained a Buy rating on Novartis AG, with a price target of CHF106.00. The ...

Novartis AG (NOVN) Receives a Buy from Kepler Capital

Novo Nordisk ( ($NVO) ) has provided an update. On November 14, 2025, Novo Nordisk A/S held an Extraordinary General Meeting to elect new members t...

Novo Nordisk Announces New Board Leadership Following Extraordinary Meeting

In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on Novo Nordisk, with a price target of $62.00. The compa...

Berenberg Bank Remains a Buy on Novo Nordisk (NVO)

Novatti Group ( ($AU:NOV) ) has shared an update. Novatti Group Limited has issued 36,363,636 fully paid ordinary shares without a prospectus, in c...

Novatti Group Issues New Shares in Compliance with Corporations Act

Novatti Group ( ($AU:NOV) ) has shared an announcement. Novatti Group Limited announced the quotation of 36,363,636 ordinary fully paid securities ...

Novatti Group Announces Quotation of New Securities on ASX

An announcement from Novatti Group ( ($AU:NOV) ) is now available. Novatti Group Limited has announced a proposed issue of 36,363,636 ordinary full...

Novatti Group Announces Proposed Issue of Securities

The latest update is out from Novatti Group ( ($AU:NOV) ). Novatti Group Limited has secured a $1 million investment from Australian Wealth Advisor...

Novatti Secures $1 Million Investment to Boost Growth

In a report released today, David Anderson from Barclays maintained a Sell rating on NOV, with a price target of $13.00. Anderson covers the Energy...

Barclays Sticks to Their Sell Rating for NOV (NOV)

In a report released yesterday, Sachin Jain from Bank of America Securities reiterated a Hold rating on Novo Nordisk, with a price target of DKK315...

Bank of America Securities Keeps Their Hold Rating on Novo Nordisk (0QIU)

DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novo Nordisk yesterday. The company’s shares closed last Friday at DKK294.70. According ...

DZ BANK AG Sticks to Its Hold Rating for Novo Nordisk (0QIU)

Enovis Corporation (($ENOV)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Enovis Corpor...

Enovis Corporation Reports Strong Growth Amid Challenges

Novanta ( ($NOVT) ) has provided an update. Novanta Inc. has announced the pricing of its public offering of $550 million in tangible equity units,...

Novanta Inc. Prices $550 Million Tangible Equity Units Offering

In a report released on November 5, David Evans from Kepler Capital maintained a Buy rating on Novo Nordisk, with a price target of DKK510.00. The ...

Kepler Capital  Reaffirms Their Buy Rating on Novo Nordisk (0QIU)

The latest announcement is out from Novo Nordisk ( ($NVO) ). Novo Nordisk reported a 12% increase in sales in Danish kroner and a 15% rise at const...

Novo Nordisk Reports Strong Sales Growth Amid Restructuring Costs

In a report released today, Michael Leuchten from Jefferies maintained a Sell rating on Novo Nordisk, with a price target of DKK290.00. The company...

Jefferies Remains a Sell on Novo Nordisk (0QIU)

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk, with a price target of DKK500.00. The company’...

J.P. Morgan Sticks to Its Buy Rating for Novo Nordisk (0QIU)

Novanta ( ($NOVT) ) has released its Q3 earnings. Here is a breakdown of the information Novanta presented to its investors. Novanta Inc. is a lead...

Novanta Reports Modest Revenue Growth in Q3 2025

Novanta (($NOVT)) has held its Q3 earnings call. Read on for the main highlights of the call. Novanta’s recent earnings call painted a picture of o...

Novanta’s Earnings Call: Record Revenue and Positive Outlook

The latest announcement is out from Novanta ( ($NOVT) ). Novanta Inc. reported its financial results for the third quarter of 2025, showing a 1.4% ...

Novanta Inc. Reports Strong Q3 2025 Financial Results

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk today and set a price target of DKK600.00. The company’s shares cl...

Deutsche Bank  Keeps Their Buy Rating on Novo Nordisk (0QIU)

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novo Nordisk, with a price target of DKK540.00. The company’...

Novo Nordisk (0QIU) Gets a Buy from Bernstein

In a report released yesterday, Jason Bandel from Evercore ISI maintained a Hold rating on NOV, with a price target of $15.00. The company’s shares...

Evercore ISI Reaffirms Their Hold Rating on NOV (NOV)

DZ BANK AG analyst Elmar Kraus maintained a Buy rating on Novartis AG today. The company’s shares opened today at CHF97.80. Kraus covers the Health...

DZ BANK AG Keeps Their Buy Rating on Novartis AG (NOVN)

NOV Inc. ( ($NOV) ) has released its Q3 earnings. Here is a breakdown of the information NOV Inc. presented to its investors. NOV Inc., a leading p...

NOV Inc. Reports Q3 2025 Financial Results

In a report released yesterday, Thibault Boutherin from Morgan Stanley maintained a Hold rating on Novartis AG, with a price target of CHF108.00. T...

Morgan Stanley Sticks to Their Hold Rating for Novartis AG (NOVN)

Bernstein analyst Florent Cespedes maintained a Buy rating on Novartis AG today and set a price target of CHF108.00. The company’s shares opened to...

Novartis AG (NOVN) Gets a Buy from Bernstein

In a report released today, Benjamin Jackson CFA from Jefferies maintained a Hold rating on Novartis AG, with a price target of CHF110.00. The comp...

Market Cap	$5.62B	P/E Ratio	16.20
52W High	$16.84	52W Low	$10.84
Div Yield	30.0%	Payout Ratio	92.1%
EPS Growth 3Y	65.0%	52W Position	67.8%
Overall Score	83	Value Score	100
Quality Score	--	Technical Score	66

EPS Current Est	$0.92	EPS Next Est	$1.06
EPS Growth Est	+15.2%	DPS Growth 3Y	77.6%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NOV	$14.91	+3.65%	1.22M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NOV	$14.91	+3.7%	1.22M
3
4
5
6

NOV

NOV

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get NOV Inc. Data in Excel

Get NOV Inc. Data in Excel